Published in Cancer Weekly, August 23rd, 1999
V. Roginskaya and colleagues from the Children's Hospital of Pittsburgh, Pennsylvania, investigated therapeutic targeting of Src-kinase Lyn in myeloid leukemic cell growth. Their study results were published in the journal Leukemia ("Therapeutic Targeting of Src-Kinase Lyn in Myeloid Leukemic Cell Growth," Leukemia, June 1999;13(6):855-861).
"Protein tyrosine kinases play a major role in promoting cell growth, and their activity in solid tumors is well established," wrote Roginskaya et al. "Inhibitors of protein tyrosine kinases are now in advanced...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.